Bioactive Compounds in Metabolic Syndrome Tug-of-War

Dear Colleagues,

Metabolic syndrome is a clustering of risk factors, including abdominal obesity, hypertriglyceridemia, low HDL levels, hyperglycemia, and hypertension. People who have three or more of these risk factors will be diagnosed with metabolic syndrome. This serious health condition could directly increase the prevalence of cardiovascular disease (CVD), type 2 diabetes mellitus, and stroke. Over the past 40 years, the prevalence of metabolic syndrome has significantly boosted with the parallel of the increasing global epidemic of obesity. Healthy lifestyle interventions are recommended to fight metabolic syndrome, such as increasing physical activity, eating healthy food, and maintaining the proper body weight. Bioactive compound intake is another choice that is expected to prevent or treat metabolic syndrome.

Therefore, this Special Issue in Molecules focuses on the Tug-of-War of bioactive compounds combat to metabolic syndrome, including but not limited to:

• New bioactive compounds discovery and the related molecular mechanism research on metabolic syndrome and the related disease, including obesity, diabetes, CVD, and stroke
• Bioactive compounds work on inflammation, carcinogenesis, gut microbiota, body-brain crosstalk focusing on obesity and brain function, etc.
• Methodology for optimizing bioactive compounds discovery.

We welcome the researchers to share their findings in this field, both in the form of original research or review articles.

Prof. Dr. Liqing Zang
Prof. Dr. Yasuhito Shimada
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.